These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12938267)

  • 21. [A pilot study of TS-1+CDDP therapy for highly advanced stage IV gastric cancer].
    Sakai Y; Saotome T; Fujimori M; Shimizu S; Inkyo T; Yugeta H; Ohbu M; Koma Y; Sato T; Nagashima F; Hayasaka A; Fukuyama Y; Tsuchiya S; Tsuyuguchi T; Saisho H
    Gan To Kagaku Ryoho; 2005 Sep; 32(9):1319-22. PubMed ID: 16184932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of scirrhous gastric cancer with peritoneal metastases successfully treated by combined chemotherapy of biweekly paclitaxel and TS-1 followed by curative resection].
    Yoshida K; Yamaguchi S; Kawaguchi A
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):601-4. PubMed ID: 17431348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A gastric cancer showing marked improvement (stage IV) with lentinan immunotherapy and 5-FU, MMC-chemotherapy].
    Horiguchi M; Saito A; Sonoda H
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1973-7. PubMed ID: 2838002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A Case of advanced gastric cancer successfully treated with TS-1/low-dose CDDP as neoadjuvant chemotherapy].
    Yamada K; Sugiyama Y; Seino K; Kobori H; Ebina T; Shibata S; Kawasaki H; Sasaki M; Tanaka M
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1447-51. PubMed ID: 16227746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey.
    Taguchi T
    Cancer Detect Prev Suppl; 1987; 1():333-49. PubMed ID: 3121179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
    Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T;
    Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination chemotherapy of TS-1 +cisplatin for inoperable gastric cancer].
    Koizumi W; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Nagaba S; Azuma M; Shimoda T; Nishimura K; Nakatani K; Saigenji K
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1957-61. PubMed ID: 15570920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701).
    Yoshino S; Nishikawa K; Morita S; Takahashi T; Sakata K; Nagao J; Nemoto H; Murakami N; Matsuda T; Hasegawa H; Shimizu R; Yoshikawa T; Osanai H; Imano M; Naitoh H; Tanaka A; Tajiri T; Gochi A; Suzuki M; Sakamoto J; Saji S; Oka M
    Eur J Cancer; 2016 Sep; 65():164-71. PubMed ID: 27501505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A recent trial of chemo-radiation with S-1 against gastric cancer].
    Saikawa Y; Kiyota T; Nakamura R; Wada N; Yoshida M; Kubota T; Kumai K; Shigematsu N; Kubo A; Kitajima M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():99-105. PubMed ID: 16897982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of advanced gastric cancer with peritoneal dissemination effectively treated by combined chemotherapy of paclitaxel (TXL) and TS-1].
    Kuriyama H; Nonaka T; Sawatari T; Tsuboi H; Akanuma M; Hata Y
    Gan To Kagaku Ryoho; 2005 May; 32(5):663-5. PubMed ID: 15918568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of endoscopic intratumoral injection of lentinan in patients with gastric cancer].
    Inagaki T; Morise K; Matsunaga H
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):319-24. PubMed ID: 3257678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A trial of biweekly paclitaxel administration in consideration of QOL for advanced or recurrent gynecologic cancer].
    Fushiki H; Yoshimoto H; Ikoma T; Ota S
    Gan To Kagaku Ryoho; 2005 May; 32(5):691-3. PubMed ID: 15918575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Trial of outpatient anti-cancer chemotherapy with infusion of 5-FU and cisplatin for advanced gastric and colorectal cancers].
    Suzuki H; Kanou Y; Ooshima H; Kawase J; Kudou J; Mizuno Y; Matsumoto S
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):189-93. PubMed ID: 15751631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Safety and efficacy of chemotherapy using TS-1 followed by paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination].
    Ohashi M; Kanda T; Yajima K; Banba T; Tanabe T; Kosugi S; Hatakeyama K
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1640-2. PubMed ID: 16315894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effective treatment of unresectable advanced gastric cancer by TS-1-based chemotherapy with a sequential combination of cisplatin (CDDP) and paclitaxel (PTX)].
    Takagi T; Ueda N; Kanemoto H
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1453-6. PubMed ID: 16227747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of 2-week TS-1 administration followed by 1-week rest for gastric cancer.
    Imamura H; Furukawa H; Kishimoto T; Nakae S; Inoue K; Tsukahara Y; Imano M; Yamazaki K; Okano S; Morimoto T; Sugihara S; Shimokawa T
    Hepatogastroenterology; 2007; 54(79):2167-71. PubMed ID: 18251183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.
    Gu Y; Shu Y; Xu Q
    Biomed Pharmacother; 2009 May; 63(4):293-6. PubMed ID: 18848761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer.
    Inada S; Tomidokoro T; Fukunari H; Sato T; Hatano T; Nishimura A; Kawauchi Y; Nikkuni K; Shimizu T; Sato T; Yanagi M; Takahashi S; Yoshida H; Sugita M; Hayashi T
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):267-73. PubMed ID: 18379784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical evaluation, including QOL of TS-1 for patients with locally advanced or recurrent gastric cancer at ambulatory setting].
    Oeda M; Hirabayashi N; Takiyama W; Nagamine I; Ohara M; Oshita A; Satou Y; Saeki S; Kirihara Y; Mukaida H; Hisamatu K
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1453-8. PubMed ID: 14584277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study.
    Tsuji A; Shima Y; Morita S; Uchida M; Okamoto K; Morita M; Horimi T; Shirasaka T
    Anticancer Res; 2008; 28(2B):1433-8. PubMed ID: 18505092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.